TCW Group Inc. Acquires 33,937 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

TCW Group Inc. grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 6.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 533,352 shares of the company's stock after acquiring an additional 33,937 shares during the period. TCW Group Inc. owned 0.12% of GE HealthCare Technologies worth $50,055,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. QRG Capital Management Inc. lifted its holdings in GE HealthCare Technologies by 5.9% during the 2nd quarter. QRG Capital Management Inc. now owns 6,643 shares of the company's stock worth $518,000 after buying an additional 370 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 1.9% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 9,276 shares of the company's stock valued at $723,000 after purchasing an additional 174 shares during the last quarter. Wedmont Private Capital grew its position in shares of GE HealthCare Technologies by 5.4% during the 2nd quarter. Wedmont Private Capital now owns 4,807 shares of the company's stock worth $386,000 after buying an additional 246 shares during the period. M&G Plc raised its stake in shares of GE HealthCare Technologies by 4.7% during the second quarter. M&G Plc now owns 79,422 shares of the company's stock worth $6,195,000 after buying an additional 3,547 shares during the last quarter. Finally, ORG Partners LLC lifted its holdings in GE HealthCare Technologies by 2,475.0% in the second quarter. ORG Partners LLC now owns 412 shares of the company's stock valued at $32,000 after buying an additional 396 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 0.5 %

Shares of GE HealthCare Technologies stock traded up $0.39 during trading on Wednesday, reaching $82.75. The stock had a trading volume of 3,890,078 shares, compared to its average volume of 3,056,573. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $37.81 billion, a price-to-earnings ratio of 22.63, a P/E/G ratio of 2.91 and a beta of 1.08. GE HealthCare Technologies Inc. has a 52 week low of $71.24 and a 52 week high of $94.55. The stock has a fifty day moving average price of $86.37 and a two-hundred day moving average price of $83.72.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the prior year, the firm posted $0.99 EPS. The business's revenue was up .9% on a year-over-year basis. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a $0.035 dividend. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies's payout ratio is presently 3.85%.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares of the company's stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.27% of the company's stock.

Analysts Set New Price Targets

GEHC has been the subject of several recent research reports. Stifel Nicolaus upped their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research report on Monday, September 30th. Evercore ISI upped their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a report on Monday, September 9th. They set a "neutral" rating and a $90.00 target price on the stock. BTIG Research upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price target on the stock in a research report on Wednesday, September 18th. Finally, Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of "Moderate Buy" and a consensus target price of $95.46.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.